nach oben

Sleep and Breathing

Erschienen in:

12.08.2021 | Sleep Breathing Physiology and Disorders • Original Article

High flow nasal cannula therapy for obstructive sleep apnea in adults

verfasst von: Hu Yan, Li Qinghua, Pi Mengyuan, Chen Yaoyu, Zhao Long, Li Mengjie, Dong Xiaosong, Han Fang

Erschienen in: Sleep and Breathing | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Obstructive sleep apnea hypopnea syndrome (OSAHS) is characterized by the aggravation of upper airway constriction or obstruction, and it is associated with high incidence of various metabolic diseases and high mortality. Continuous positive airway pressure (CPAP) is now recommended as the first-line therapy for OSAHS, but its application is limited by its unsatisfactory patient tolerance. Previous studies have showed that high flow nasal cannula (HFNC) may improve symptoms in some patients with OSAHS. Therefore, the aim of the present study was to evaluate the effect of HFNC on OSAHS in a larger cohort than in previous research and to study the details of its therapeutic characteristics.

Methods

Polysomnography recording with and without HFNC was performed in 56 OSAHS patients with a wide spectrum of disease severity. Subgroups were divided by different treatment response criteria to identify the effect of this device.

Results

Of 56 patients enrolled, 9 were of mild severity (AHI, 5 to <15 events/h), 30 were of moderate severity (AHI, 15 to <30 events/h), and 17 patients were severe (AHI ≥ 30 events/h); 34 patients were younger than 50 years old and 22 patients were older than 50 years old. AHI decreased significantly (from 26.9 ± 14.7 to 21.5 ± 17.0 events/h, p < 0.001) after HFNC treatment in general. The subjects of responder group accounted for 21%. There was a negative correlation between the difference of AI and the difference of HI in nonresponder group before and after HFNC treatment, and the negative correlation was strong (Pearson’s test, r = − 0.804, p = 0.000). Of the patients with mild to moderate severity, 76% achieved any AHI reduction and 24% of patients achieved at least 50% reduction in AHI. Older patients (the age of responder group 52.6 ± 11.7 vs. nonresponder group 43.7 ± 12.1 years old, p < 0.05), especially patients older than 50 years, had a better response rate (≤ 50 years 9% vs. > 50 years 41%, p = 0.007).

Conclusion

HFNC may be useful in treating patients with OSAHS, especially older patients and those with mild to moderate severity. HFNC may be an alternative treatment when patients are intolerant of CPAP.

Drake CL, Day R, Hudgel D et al (2003) Sleep during titration predicts continuous positive airway pressure compliance. Sleep 26:308–311. https://doi.org/10.1093/sleep/26.3.308CrossRefPubMed

Smith PL, Wise RA, Gold AR et al (1985) Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol 1988(64):789–795. https://doi.org/10.1152/jappl.1988.64.2.789CrossRef

Mansour KF, Rowley JA, Meshenish AA et al (1985) A mathematical model to detect inspiratory flow limitation during sleep. J Appl Physiol 2002(93):1084–1092. https://doi.org/10.1152/japplphysiol.01140.2001CrossRef

Arzt M, Young T, Finn L et al (2005) Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172:1447–1451. https://doi.org/10.1164/rccm.200505-702OCCrossRefPubMedPubMedCentral

Gleadhill IC, Schwartz AR, Schubert N et al (1991) Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am Rev Respir Dis 143:1300–1303. https://doi.org/10.1164/ajrccm/143.6.1300CrossRefPubMed

Weaver TE, Maislin G, Dinges DF et al (2003) Self-efficacy in sleep apnea: instrument development and patient perceptions of obstructive sleep apnea risk, treatment benefit, and volition to use continuous positive airway pressure. Sleep 26:727–732. https://doi.org/10.1093/sleep/26.6.727CrossRefPubMed

McGinley BM, Patil SP, Kirkness JP et al (2007) A nasal cannula can be used to treat obstructive sleep apnea. Am J Respir Crit Care Med 176:194–200. https://doi.org/10.1164/rccm.200609-1336OCCrossRefPubMedPubMedCentral

Aloia MS, Stanchina M, Arnedt JT et al (2005) Treatment adherence and outcomes in flexible vs standard continuous positive airway pressure therapy. Chest 127:2085–2093. https://doi.org/10.1378/chest.127.6.2085CrossRefPubMed

Olson EJ, Moore WR, Morgenthaler TI et al (2003) Obstructive sleep apnea-hypopnea syndrome. Mayo Clin Proc 78:1545–1552. https://doi.org/10.4065/78.12.1545CrossRefPubMed

10.

Schwartz AR, Smith PL, Wise RA et al (1985) Effect of positive nasal pressure on upper airway pressure-flow relationships. J Appl Physiol 1989(66):1626–1634. https://doi.org/10.1152/jappl.1989.66.4.1626CrossRef

11.

de Klerk A (2008) Humidified high-flow nasal cannula: is it the new and improved CPAP? Adv Neonatal Care 8:98–106. https://doi.org/10.1097/01.ANC.0000317258.53330.18CrossRefPubMed

12.

Eastwood PR, Szollosi I, Platt PR et al (2002) Comparison of upper airway collapse during general anaesthesia and sleep. Lancet 359:1207–1209. https://doi.org/10.1016/S0140-6736(02)08224-7CrossRefPubMed

13.

Nilius G, Wessendorf T, Maurer J et al (2010) Predictors for treating obstructive sleep apnea with an open nasal cannula system (transnasal insufflation). Chest 137:521–528. https://doi.org/10.1378/chest.09-0357CrossRefPubMed

14.

Sowho MO, Woods MJ, Biselli P et al (2015) Nasal insufflation treatment adherence in obstructive sleep apnea. Sleep Breath 19:351–357. https://doi.org/10.1007/s11325-014-1027-4CrossRefPubMed

15.

(1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22: 667–689

16.

Aloia MS, Ilniczky N, Di Dio P et al (2003) Neuropsychological changes and treatment compliance in older adults with sleep apnea. J Psychosom Res 54:71–76. https://doi.org/10.1016/s0022-3999(02)00548-2CrossRefPubMed

17.

Eckert DJ, Malhotra A, Lo YL et al (2009) The influence of obstructive sleep apnea and gender on genioglossus activity during rapid eye movement sleep. Chest 135:957–964. https://doi.org/10.1378/chest.08-2292CrossRefPubMed

18.

Marin JM, Carrizo SJ, Vicente E et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053. https://doi.org/10.1016/S0140-6736(05)71141-7CrossRefPubMed

19.

Spoletini G, Alotaibi M, Blasi F et al (2015) Heated Humidified High-Flow Nasal Oxygen in Adults: Mechanisms of Action and Clinical Implications. Chest 148:253–261. https://doi.org/10.1378/chest.14-2871CrossRefPubMed

20.

Findley LJ, Wilhoit SC, Suratt PM (1985) Apnea duration and hypoxemia during REM sleep in patients with obstructive sleep apnea. Chest 87:432–436. https://doi.org/10.1378/chest.87.4.432CrossRefPubMed

21.

Oliven A, Carmi N, Coleman R et al (2001) Age-related changes in upper airway muscles morphological and oxidative properties. Exp Gerontol 36:1673–1686. https://doi.org/10.1016/s0531-5565(01)00127-9CrossRefPubMed

Titel: High flow nasal cannula therapy for obstructive sleep apnea in adults
verfasst von: Hu Yan
Li Qinghua
Pi Mengyuan
Chen Yaoyu
Zhao Long
Li Mengjie
Dong Xiaosong
Han Fang
Publikationsdatum: 12.08.2021
Verlag: Springer International Publishing
Erschienen in: Sleep and Breathing / Ausgabe 2/2022
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-021-02453-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

High flow nasal cannula therapy for obstructive sleep apnea in adults